期刊文献+

β受体阻滞在心血管疾病中的临床应用研究进展 被引量:4

Application Progress of β-receptor Blocker in the Treatment of cardiovascular Diseas
下载PDF
导出
摘要 依据国内外的临床研究和循证医学分析,对β受体阻滞剂在心血管疾病方面的合理应用以及适应证,给药方法进行循证性举证,提示β受体阻滞剂可明显改善心血管疾病的临床预后,除非有禁忌证及不能酎受者,β受体阻滞剂应作为心血管疾病的常规治疗病物广泛应用于心血管疾病。 Through the analysis of β-receptor blocker about its reasonable application, indication and medication based on clinical study and evidence-based medicine,it is suggested that β-receptor blocker can promote the prognosis of patients with cardiovascular diseases obviously, which should be used widely in cardiovascular diseases as conventional therapeutic drug except for some contraindications or unbearable patients.
出处 《医学综述》 2006年第16期1015-1018,共4页 Medical Recapitulate
关键词 Β受体阻滞剂 心血管疾病 心肌梗死 心力衰竭 Cardiovascular disease β-receptor blocker Myocardialinfarcfion Heart failure
  • 相关文献

参考文献20

二级参考文献124

  • 1陶萍,龙露,诸骏仁.索他洛尔对室性心律失常的疗效及安全性(双盲随机对照试验)[J].中华心血管病杂志,1996,24(6):408-410. 被引量:46
  • 2[1]Ruffolo RR, Feuerstein GZ. Carvedilol:preclinical profile and mechanisms of action in preventing the progression of congestive heart failure [J] .Eur Heart J, 1998,19[ Suppl B] :B19-B24. 被引量:1
  • 3[2]Esler M, Kaye D, Lambert G, et al. Adrenergic nervous system in Heart Failure[J] .Am J Cardiol, 1997,80(11A) :7L-14L. 被引量:1
  • 4[3]Bristow MR. Mechanism of action of beta-blocking agent in heart failure[J]. Am J Cardiol, 1997,80(llA) :26L-40L. 被引量:1
  • 5[4]Lohmeiar TE, Lohmeier JR, Warren S, et al. Sustained activation of the central baroreceptor pathway in angiotensin hypertension[J]. Hypertension,2002,39(2) :550-556. 被引量:1
  • 6[5]Lechat PP, Chalon S, Cucheat M, et al. Meta-analysis of randomized clinical trials on beta-blocker treatment in heart failure[J]. Circulation,1996,94[ Suppl I] :665. 被引量:1
  • 7[6]Packer M, Antonopoulos GV, Berlin JA, et al. Comparative effects of carvedilol and metoprolol on left ventricular ejection fraction in heart failure: Result of a meta-analysis[ J] . Am Heart J, 2001,141 (6): 899-907. 被引量:1
  • 8[7]Azevedo ER, Kubo T, Mai S, et al. Nonselective versus selective betaedrenergic receptor blockade in congestive heart failure:differential effects on sympathetic activity [J]. Circulation, 2001,104 ( 18 ): 2194-2199. 被引量:1
  • 9[8]Vittorio TJ, Lang CC, Katz SD, et al. Vasopressor response to angiotensin Ⅱ infusion in patients with chronic heart failure receiving β-blockers[J]. Circulation, 2003,107(2): 290-293. 被引量:1
  • 10[9]Feuerstein GZ,Ruffolo RR.Carvedilol:a novel vasodilating beta-blocker with the potential for cardiovascular organ protection[J]. Eur Heart J, 1996,17[ Suppl B] :24-29. 被引量:1

共引文献8011

同被引文献21

引证文献4

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部